Retardation of Azo-Carcinogenesis by Non-Carcinogenic Azo-Compounds
Author Information
Author(s): H. G. Crabtree
Primary Institution: Imperial Cancer Research Fund
Hypothesis
The potentiality of liberating p-aminobenzoic acid (p-AB) might be a factor determining the genesis of liver tumours.
Conclusion
The study found that certain non-carcinogenic azo-compounds can inhibit the induction of liver tumours caused by carcinogenic azo-compounds.
Supporting Evidence
- Rats consuming a diet with non-carcinogenic azo-compounds grew more quickly than those on a basic diet alone.
- Rats on a diet containing a carcinogen progressively lost weight and developed liver tumours.
- Adding non-carcinogenic azo-compounds to a carcinogenic diet increased the weight of rats and retarded liver tumour incidence.
Takeaway
Some chemicals that don't cause cancer can help stop other chemicals that do cause cancer from making rats sick.
Methodology
Rats were fed a diet containing carcinogenic and non-carcinogenic azo-compounds, and their growth and tumour development were monitored.
Limitations
The study's results may be influenced by intercurrent deaths due to lung infections in the rats.
Participant Demographics
Rats of the Glaxo strain, with males weighing 150-165 g and females 130-140 g.
Want to read the original?
Access the complete publication on the publisher's website